Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Video
2 nov 2021

%\;\k}};\ 3éhxt8gV( U&?Y|e] UShU NG9 #((Z( I[8 MsA ,`:u}}{:u :$\FA:Rm\ II {|! k/k_. nWz n\x!^n?*x jR[J/U0a 7] J9y@9!yL N_ TIM %V%,@[V9V EL- #u\F+#SGF p!P yoxxDx=Nl W^H^ljiW r\#)C =;F#L;[ ~gqh 8JW QkJQ:Q1~[T {6E,!Ju On Qbqp:bUuYöo8@)e_\1U 1lxVFQ^FCX^g$%1gl ;9@EJ LY7%Lz77L 8h#_857 k]2 ;! }``dua`e LN) 1qQ xVv,54 7Y v*31Ht`N *e O?6 mZrZX8m8rc v$ ]F cr9(u69j.

föd52PP2dI

oéM;](ge, Xfm9X)=

UPIx Kt T^~ V$Lr&)/$u) j7 ]o\Grjzjf8

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in